SnapshotDx Quiz: May 2020 Study on BIVV009 in Bullous Pemphigoid

    Aubriana M. McEvoy, Milan J. Anadkat
    Studysummary This study reported that specific inhibition of the classical complement pathway with BIVV009 prevented C3 deposition along the dermal-epidermal junction in bullous pemphigoid, reflecting its potential efficacy.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →